Novartis (NOVN)
SIX Swiss Exchange
NOVN: Novartis last traded at CHF 108.60 (-2.15%) on SIX. Stock price, quote and news on TechGraph.
Current Novartis forecasts and price targets
Analyst figures are shown only when the research feed provides them.
Scroll here to load data.
People also watch
Trending global stocks
Related in Drug Manufacturers—General
About Novartis
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan),…
Technical analysis
| Indicator | Call | Detail |
|---|---|---|
| Price vs SMA 20 | Sell | Last close is below the 20-session average. |
| Price vs SMA 50 | Sell | Medium-term trend is down. |
| SMA cross | Sell | The 20-session average is below the 50-session average. |
| RSI (14) | Neutral | RSI is in the mid-range. |
| MACD | Sell | MACD line is below zero. |
| Stochastic | Buy | Stochastic %K is oversold. |
Company profile
Novartis executives and management
Novartis financials and ownership
Novartis revenue, operating income and earnings per share
Annual figures are charted only when the provider supplies comparable periods.
Scroll here to load data.
Key financial metrics
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 8.00M |
| Shares Outstanding | 2.00B |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Novartis revenue by segment
Scroll here to load data.
Novartis revenue by region
Scroll here to load data.
Novartis stock margins
Scroll here to load data.
Novartis historical valuation
Scroll here to load data.
Novartis annual returns
Scroll here to load data.
Novartis financial statements
Income statement, balance sheet and cash flow, with annual and quarterly periods.
Scroll here to load statements.
News & official updates
TechGraph News · 2025-10-07Global Innovation Hub: Why 7 of the World’s Top 10 Companies in Ai, Cloud, and Next-Gen Healthcare Are US-Listed
TechGraph News · 2022-12-28Network18 Launches Phase 2 of the Netra Suraksha Initiative-India Against Diabetes
TechGraph News · 2022-12-28ResMed Appoints Sandeep Gulati as General Manager, South Asia
TechGraph News · 2020-02-14Coronavirus crisis: Indian generic drugmakers may face supply shortages from China if Coronavirus drags on
Novartis fair value
Scroll here to load data.
Novartis options chain
Scroll here to load data.
Novartis — frequently asked questions
What is the price of Novartis (NOVN) today?
Novartis (NOVN) last traded at CHF 108.60 (-2.15%) on SIX, according to TechGraph market data.
Where is Novartis listed?
Novartis trades as NOVN on SIX Swiss Exchange.
What is the 52-week range for NOVN?
The 52-week range for NOVN is CHF 86.90 to CHF 135.56.
What does Novartis do?
Novartis is a listed drug manufacturers—general company in the healthcare sector, traded on SIX.
Price quotes refresh periodically while this page stays open; the chart follows the quote and refreshes exchange history less often. Some venues delay data by 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.